Stanford Uncovers Rare mRNA Vaccine Myocarditis Pathway, Soy Compound Role

Stanford researchers identified a two-step immune mechanism behind rare mRNA vaccine-linked myocarditis, predominantly in young males. They also found a soy-derived compound, genistein, could potentially mitigate this inflammation in models. The study reiterates vaccines are safe, with COVID-19 infection posing a higher myocarditis risk.

Read the full story on Quick Digest